Physician profile
Drew Prasad
NPI 1174074108
$8,402.11
in general payments reported to CMS, 2019-2025
11 companies · $1,727 in 2025
The $1,727 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,937 · 2022: $2,108 · 2023: $1,443 · 2024: $1,187 · 2025: $1,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,009 · Travel and Lodging: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,009.20 |
| Travel and Lodging | $347.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $6,956.68 | 2021-2025 | |
| Abbott Laboratories | $328.61 | 2024 | Proclaim |
| Depuy Synthes Sales INC. | $299.73 | 2021-2025 | Teligen, Symphony, Expedium Verse |
| Medtronic, INC. | $299.65 | 2022-2025 | N/A, Inceptiv |
| Alphatec Spine, INC | $142.86 | 2022 | |
| Nevro Corp. | $106.90 | 2021 | |
| Stryker Corporation | $85.30 | 2022 | |
| Medinc of Texas | $82.27 | 2022 | |
| Globus Medical, INC. | $54.78 | 2025 | Creo |
| Core Surgical Group | $25.53 | 2025 | |
| Olympus America INC. | $19.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Prasad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.